IL-5 but not interferon-gamma (IFN-γ) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 198-204

  Ochiai, K ^a   Kagami, M ^a   Matsumura, R ^a   Tomioka, H ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antisense DNA; bcl 2; Eosinophil apoptosis; IFN ; IL 5

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 5;

APOPTOSIS; ARTICLE; CELL LINE; CLINICAL ARTICLE; EOSINOPHIL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0031014771     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-884.x     Document Type: Article

References (25)

1. Tsujimoto Y, Finger LR, Yunis J., Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science 1984; 226:1097-9.
2. Bakhshi A, Jensen JP, Goldman P. Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41:889-906.
3. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985; 82:7439-43.
4. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986; 83:5214-8.
5. Nunez G, London L, Hockenbery D, Alexander M, Mckearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoitic cell lines. J Immunol 1990; 144:3602.
6. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA, Della-Porta G. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992; 79:1291.
7. Naumovski L, Cleary ML. Bcl-2 inhibits apoptosis associated with termina differentiation of HL-60 myeloid leukemia cells. Blood 1994; 83:2261.
8. Lagasse E, Weissman IL. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 1994; 179:1047.
9. Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A, Warallan AJ, Kay AB. Expression of mRNA and immunoreactivity for the granulocyte macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 1991; 174:749.
10. Desreumaux P, Janin A, Colombel JF et al. Interleukin-5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 1992; 175:293.
11. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulaling factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992; 90:1414.
12. Yamaguchi Y, Hayashi Y, Sugama Y et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988; 167:1737.
13. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992; 148:3543.
14. Ochiai K, Iwamoto I, Takahashi H, Yoshida S, Tomioka H, Yoshida S. Effect of interleukin-4 and Interferon-γ on interleukin-3- and interleukin-5-induced eosinophil differentiation from human cord blood mononuclear cells. Clin Exp Immunol 1995; 99:124.
15. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991; 147: 3490.
16. Ochiai K, Iwamoto I, Takahashi H, Yoshida S, Nakagawa N, Tomioka H, Yoshida S. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia. Clin Exp Immunol 1991; 84:282.
17. Hansel TT, Pound JD, Pilling D, Kitas GD, Salmon M, Gentle TA, Lee SS, Thompson RA. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 1989; 122:97.
18. Park JR, Rohertson K, Hickstein DD, Tsai S, Hockenbery DM. Collins SJ. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 1994; 84:440.
19. Paul WE, Seder RA. Lymphocyte responses of cytokines. Cell 1994; 76:241.
20. Kamesaki H, Zweibel JA, Reed JC, Cossman J. Role of bcl-2 and IL-5 in the regulation of anti-IgM-induced growth arrest and apoptosis in immature B cell lines. A cooperative regulation model for B cell clonal deletion. J Immunol 1994; 152:3294.
21. Kelso A, Troutt AB. Survival of myeloid progenitor cell line FDC-P1 is prolonged by interferon-gamma or interleukin-4. Growth Factors, 1994; 6:233.
22. Kobayashi R, Rassenti LZ, Meisenholder G, Carson DA, Kipps TJ. Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor. J Immunol 1993; 151:7273.
23. Olitvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609.
24. Yin XM, Olitvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369:272.
25. Boise LH, Gonzalez-Garcia M, Postema CE et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74:597.